SecBot SecBot
Institutional Cluster

CCCC

C4 Therapeutics, Inc.
BULLISH
Impact 6/10
Horizonweeks Processed8mo ago
Institutional cluster: 3 buyers, 0 sellers (bullish)
Actionable Insight ▲ Bullish

The coordinated buying by three large passive managers suggests growing confidence in CCCC’s pipeline or valuation, potentially ahead of clinical catalysts. Traders should monitor for upcoming trial data or partnerships as potential near-term triggers.

DirectionBullish
Confidencehigh
Horizonweeks

How the stock moved after the report

BULLISH VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$3.17
T+0 close · Feb 28, 2026 · via day close
Latest settled
+10.09%
T+60 · $3.49
Vs SPY
+0.77%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Mar 2 $3.17entry
  2. T+1 · 9mo ago −6.94%α −6.03% · $2.95
  3. T+5 · 8mo ago +13.25%α +14.46% · $3.59
  4. T+20 · 8mo ago −25.87%α −17.93% · $2.35
  5. T+60 · 6mo ago +10.09%α +0.77% · $3.49

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Three major institutional investors, Morgan Stanley, Wells Fargo, and UBS, increased their positions in C4 Therapeutics (CCCC) during Q4 2024, with UBS doubling its stake. The aggregate buying activity totaled $1.4M in net new investment, signaling growing institutional interest in the small-cap biotech firm.

Key Financial Metrics

Direction
accumulating
Buy Value
$1.4M
Net Flow
$1.4M

Institutional Positions

Net institutional flow: $1.4M

▲ Buyers (3)

InstitutionActionChangePosition ValueValue Δ
Morgan StanleyADD+65.1%$13.8M$563.0K
UBSDOUBLED+126.8%$2.7M$824.0K
Wells FargoADD+34.9%$131.0K-$22.7K

Key Facts

  • Morgan Stanley increased its stake by 65.1%, adding 1.51M shares with a value increase of $563K to a total of $13.8M.
  • UBS doubled its position, increasing shares by 126.8% (423.8K shares added), growing its investment value by $824K to $2.7M.
  • Wells Fargo added 9.4K shares (+34.9%), though the value of its position decreased slightly by $22,725 to $131K, likely due to share price movement during the period.
  • No institutional selling was observed, all three tracked institutions were net buyers.

Financial Impact

Institutions added $1.4M in net new positions during Q4 2024, with total current holdings now at $16.7M.

market_capfloat_demandinstitutional_ownership

Risk Factors

  • All buyers are classified as mega-passive institutions, which may indicate index-driven or model-based buying rather than high-conviction active bets.
  • CCCC has a small market cap ($401M), making it vulnerable to volatility if sentiment shifts or institutions rebalance.

Market Snapshot

Exchange
Nasdaq

Investment Themes

Documents Analyzed

This report is based on 1 institutional 13F filing from SEC EDGAR.

DocumentAccession Number
INST-CLUSTER Data (Synthetic)inst-cluster-CCCC-2024-Q4

US Market Status

Market Closed · Opens in 6h 31m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Feb 28, 2026